Dexcom G7 Now Connects Directly to Apple Watch in the U.S.

Rhea-AI Summary

Dexcom has announced that its G7 Continuous Glucose Monitoring (CGM) System now connects directly to Apple Watch in the U.S. This integration allows users to receive real-time glucose readings on their wrist without needing their iPhone. Dexcom G7 is the first CGM system to offer this feature, enhancing convenience and flexibility in diabetes management. The feature is available in the U.S., U.K., and Ireland, with more regions to follow. Users must have the Dexcom G7 app version 2.1, Apple Watch Series 6 or later on watchOS 10 or later, and an iPhone with iOS 17 or later.

Positive

• First CGM system to connect directly to Apple Watch, creating a unique market position.
• Enhances user convenience and flexibility by allowing glucose readings on the wrist without an iPhone.
• Available in the U.S., U.K., and Ireland, with more markets to follow, indicating a broad rollout strategy.
• Integration uses Bluetooth for real-time glucose information, making the system more efficient.
• Supports health metrics tracking like activity, sleep, and cycle tracking on Apple devices.

Negative

• Requires Apple Watch Series 6 or later, and iPhone running iOS 17, limiting accessibility for some users.
• Potential cost implications for users needing to upgrade their Apple devices to use this feature.

Insights

Tech Expert

Dexcom G7's direct connectivity to Apple Watch is a significant technological advancement in the field of continuous glucose monitoring (CGM). This new feature eliminates the intermediary requirement of an iPhone, thereby offering greater convenience and freedom to users. By leveraging a dedicated Bluetooth connection, the Apple Watch integration allows users to continuously monitor glucose levels directly on their wrist. This seamless integration aligns with the increasing trend of wearable technology being used in medical applications, enhancing user experience by making health data more accessible and convenient.

Furthermore, this feature can potentially increase the adoption rate of Dexcom G7 among individuals with diabetes who are also Apple Watch users. By consolidating important health metrics in one place, users can make more informed decisions about their health without the hassle of carrying multiple devices.

Market Research Analyst

From a market perspective, the introduction of Dexcom G7’s direct-to-Apple Watch connectivity could substantially boost Dexcom’s competitive edge in the CGM market. The integration with a popular and widely used wearable like the Apple Watch could attract a new segment of tech-savvy users. This could translate to an expansion of Dexcom's user base and potentially increase market share.

Moreover, the announcement timing aligns with the recent updates in Apple's watchOS, indicating a strategic move to capitalize on the latest software enhancements. This synergy not only showcases Dexcom's ability to innovate but also highlights the importance of strategic partnerships in tech-driven healthcare solutions.

In the short term, this could lead to a positive market sentiment towards Dexcom’s stock, as investors recognize the potential for increased sales and user engagement. In the long term, maintaining such technological advancements will be important for sustaining growth and staying ahead in a competitive market.

Financial Analyst

Assessing the financial implications, the new feature of Dexcom G7 connecting directly to Apple Watch could positively impact the company's financial performance. By offering a unique selling proposition, Dexcom may see an uptick in sales as users upgrade to or switch to the G7 system for its advanced capabilities. This could lead to an increase in revenue in the forthcoming quarters.

Additionally, the integration with Apple Watch positions Dexcom well within the lucrative wearable tech market, potentially attracting partnerships and collaborations, which could further enhance revenue streams. Investors should monitor upcoming financial reports for any indication of increased unit sales and market penetration, which would validate the anticipated financial benefits.

However, it’s important to keep an eye on any costs associated with this technological upgrade, including R&D and marketing expenses, to ensure they do not offset the projected revenue gains. Overall, if executed well, this feature could be a strong driver for financial growth.

• Diabetes management goes hands-free as Dexcom G7 now connects directly to Apple Watch^* in the U.S., giving users confidence even when their iPhone isn’t with them^†
• As the first and only CGM system that connects directly to Apple Watch,^* Dexcom G7 gives users the freedom and convenience of real-time glucose readings on their wrist
• Direct to Apple Watch is now available to Dexcom G7 users in the United States, United Kingdom and Ireland, with additional markets launching later this month

SAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that the Dexcom G7 Continuous Glucose Monitoring (CGM) System now connects directly to Apple Watch^* in the United States. Dexcom G7 is the first and only CGM available with Direct to Apple Watch, offering users the freedom and convenience of real-time glucose readings on their wrist even when their iPhone isn’t with them.^†

Diabetes management goes hands-free as Dexcom G7 now connects directly to Apple Watch in the US, giving users confidence even when their iPhone isn’t with them. (Photo: Business Wire)

“At Dexcom, our users are at the heart of everything we do. Direct to Apple Watch has been one of our most requested features and we’re thrilled to roll it out to Dexcom G7 users in the U.S. and around the world,” said Jake Leach, executive vice president and chief operating officer at Dexcom. “We’ve long believed that people with diabetes should be able to view their CGM data where and how they choose. Direct to Apple Watch is a testament to that, allowing people with diabetes flexibility and choice in how they manage their health.”

Using its own dedicated Bluetooth connection, Dexcom G7 sends glucose information and personalized alerts right to a user’s Apple Watch, allowing them to go for a run, enjoy a dinner out, and feel confident leaving their iPhone behind.^† Dexcom G7 is the only CGM system that can display glucose on multiple devices simultaneously and independently, including on a smartphone, smart watch, receiver or connected automated insulin delivery system.^‡

In addition to the benefits of using Direct to Apple Watch with Dexcom G7, people with diabetes can track other key health metrics that can impact glucose levels using Apple’s Activity, Cycle Tracking, Sleep, and other health features on Apple Watch, iPhone and iPad. All of this data is stored securely in the Health app, where it can be viewed alongside Dexcom G7 data users choose to store in the Health app so all of their diabetes health information is accessible in one place. Apple products are built with strong privacy protections and users have control over their data in the Health app.

"Having used Direct to Apple Watch with Dexcom G7 for the last few months, being able to glance at my wrist and see my glucose levels in real-time has been a game changer," said Dexcom Warrior Beth McDaniel of Northern Ireland. "For the first time since being diagnosed, I can leave my phone at home without worrying and enjoy my daily activities with the confidence that I have the information I need to help keep my diabetes under control."

Direct to Apple Watch is now available to Dexcom G7 users in the United States, United Kingdom and Ireland, with additional markets launching later this month. To use Direct to Apple Watch, users must have the Dexcom G7 app version 2.1, Apple Watch Series 6 or later running watchOS 10 or later, and an iPhone running iOS 17 or later. To learn more about Direct to Apple Watch and see a list of compatible devices, visit www.Dexcom.com/G7.

About DexCom, Inc.

DexCom, Inc. empowers people to take real-time control of health through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, Calif., and with operations across Europe and select parts of Asia/Oceania, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom works to simplify and improve diabetes management around the world. For more information about Dexcom CGM, visit www.dexcom.com.

^*Smart device sold separately. To view a list of compatible devices, visit dexcom.com/compatibility. ^†Compatible smartphone is required to pair a new Dexcom G7 sensor with a compatible Apple Watch. To use Share/Follow the smartphone must be within 20 feet of the Dexcom G7. ^‡To learn more about insulin pump integrations and compatibility with Dexcom CGM Systems, visit dexcom.com/integrate.

Category: IR

View source version on businesswire.com: https://www.businesswire.com/news/home/20240605396939/en/

Media Contact

James McIntosh

619-884-2118

james.mcintosh@dexcom.com

Investor Contact

Sean Christensen

858-203-6657

sean.christensen@dexcom.com

Source: DexCom, Inc.

FAQ

What is the new feature of the Dexcom G7?

The Dexcom G7 now connects directly to Apple Watch, allowing users to view real-time glucose readings on their wrist.

Which regions have access to the Dexcom G7 Direct to Apple Watch feature?

The feature is available in the United States, United Kingdom, and Ireland, with more markets launching later this month.

What devices are required to use Dexcom G7 Direct to Apple Watch?

Users need the Dexcom G7 app version 2.1, Apple Watch Series 6 or later running watchOS 10 or later, and an iPhone running iOS 17 or later.

How does the Dexcom G7 send glucose information to the Apple Watch?

It uses a dedicated Bluetooth connection to send real-time glucose information and personalized alerts directly to the Apple Watch.

Is the Dexcom G7 the only CGM system that connects to Apple Watch?

Yes, the Dexcom G7 is currently the only CGM system that can connect directly to Apple Watch.